IL2 and cancer: In pet dogs with cancer that deviate from successful T cell priming and activation, preempting this break in the cancer-immunity cycle (Steps 2-3) through the use of exogenous cytokines such as IL-2 and IL-12 may create the desired pro-inflammatory milieu that substantiates proliferation and activation of T cells and NK cells.